Profilo
Prior to joining SLS Venture in 2004, Mikael Mortensen was CFO at Melacure Therapeutics AB.
Before that, he held the position as acting Group Controller and Financial Manager at SchlumbergerSema (acquired by WM-data), where he was responsible for consolidating fifteen Nordic subsidiaries and financial reporting to the Group’s UK headquarters.
Between 1989 and 2000, Mikael Mortensen held various CFO positions at ETOUR, County Administration of Jämtland, Swedish National Board of Student Aid (CSN) and Riksbyggen AB.
Precedenti posizioni note di Mikael Mortensen
| Società | Posizione | Fine |
|---|---|---|
Scandinavian Life Science Ventures AB
 Scandinavian Life Science Ventures AB Investment ManagersFinance SLS Invest AB (SLS Invest) is a venture capital firm wholly-owned by Sjätte AP-fonden. The firm was established in 2007 and is headquartered in Stockholm, Sweden, with a branch office in Copenhagen, Denmark. | Direttore Finanziario/CFO | 01/12/2011 |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Health Technology |
Scandinavian Life Science Ventures AB
Scandinavian Life Science Ventures AB Investment ManagersFinance SLS Invest AB (SLS Invest) is a venture capital firm wholly-owned by Sjätte AP-fonden. The firm was established in 2007 and is headquartered in Stockholm, Sweden, with a branch office in Copenhagen, Denmark. | Finance |
- Borsa valori
- Insiders
- Mikael Mortensen
